@article{JTD22589,
author = {Jumpei Kashima and Yusuke Okuma},
title = {Harmonization study of antibodies and platforms for programmed death ligand 1 immunostaining in non-small cell lung cancer: does shuffling couples settle the troubles?},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 18},
year = {2018},
keywords = {},
abstract = {Immune-checkpoint inhibitors (ICIs) resulted in a revolution in the treatment of progressed non-small cell lung cancer (NSCLC). Blockade of programmed death 1 (PD-1) and its programmed death ligand 1 (PD-L1) has demonstrated better survival rates than cytotoxic chemotherapies.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/22589}
}